Can BAK be used in corneal cross linking?
Study links new gender and genetic factors to Fuchs Endothelial Corneal Dystrophy
A large-scale study indicates women are more likely to develop the inherited corneal condition
OKYO Pharma files US FDA Fast Track application for neuropathic corneal pain treatment urcosimod
Urcosimod, formerly known as OK-101, showed clear statistical significance in multiple endpoints in a recently completed Phase 2 trial
Novel stem cell therapy restores corneal damage previously believed irreversible
The authors said their results provide strong support that cultivated autologous limbal epithelial cell transplantation is safe and feasible
Ocular surface disease and other adverse effects linked to cosmetics, personal care products
The authors emphasised that consumers and clinicians should be made aware of potential ophthalmic adverse events associated with cosmetics and personal care products
Shifting the narrative around dry eye disease
A qualitative study method illuminates patients’ fears for the future
Plant pathogen Macrophomina phaseolina may be emerging cause of ocular infection in humans
A case report highlights the pathogen’s potential to cause severe, devastating ocular infections, despite aggressive treatment
